Milestone Pharmaceutiques Inc
EIR issued November 19, 2024 · Saint-Laurent, Canada
- Inspection
- Oct 21 – Nov 19, 2024
- Investigators
- Anthony Grace· Scott B. Laufenberg
- Pages
- 18
- FEI number
- 3031306324
In short: This is FDA's Establishment Inspection Report (EIR) for Milestone Pharmaceutiques Inc in Saint-Laurent, Quebec (FEI 3031306324), covering the inspection of Oct 21 – Nov 19, 2024. It is the investigator's full narrative of what they examined, who they spoke to and what they found. The investigators were Anthony Grace and Scott B. Laufenberg.
Inside this inspection report
The investigator's narrative
The full inspection report: what the investigator looked at, who they spoke to and what they found, in their own words.
Get the full EIRThis inspection in context
Anthony Grace
2 documents · 2024–2026
Cites 312.64 (investigator reports) more than any other section. Most of their documents are for sites in Canada.
The firmMilestone Pharmaceutiques Inc history
The site's inspection history, in date order.
Similar documentsMore eirs
Browse other documents of this type.
Questions about this EIR
Who inspected Milestone Pharmaceutiques Inc?
Anthony Grace and Scott B. Laufenberg are named on this EIR, for the inspection of Oct 21 – Nov 19, 2024. Each investigator has a profile showing what they cite most.
When was Milestone Pharmaceutiques Inc inspected by FDA?
The inspection ran Oct 21 – Nov 19, 2024.
How do I get the full EIR for Milestone Pharmaceutiques Inc?
Download the original PDF from FDA Intel for $550, with no subscription. You also get an invoice PDF with the order.